| Missing Links?: 1 Citation Matrix | Historiographs | Glossary HistCite Guide About |
|
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Zhang Z, Bast RC, Yu YH, Li JN, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, van Haaften-Day C, Hacker NF, de Bruijn HWA, van der Zee AGJ, Jacobs IJ, Fung ET, Chan DW CANCER RESEARCH 64 (16): 5882-5890 AUG 15 2004 and the citing papers |
Nodes: 93,
Authors: 471,
Journals: 56,
Outer References: 2998,
Words: 376
Yearly output |
Document Type |
Language |
Institution |
Institution with Subdivision |
Country
Collection span: 2004 - 2006
| View: Overview | Sorted by year, source, volume, issue, page. |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 23 | 1 2004 BMC BIOTECHNOLOGY 4: Art. No. 30 Kwapiszewska G; Meyer M; Bogumil R; Bohle RM; Seeger W; et al. Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS | 0 | 6 |
| 2 | 1 | 9 | 2 2004 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 13 (10): 1555-1557 Semmes OJ Defining the role of mass spectrometry in cancer diagnostics | 0 | 1 |
| 3 | 0 | 50 | 3 2004 CANCER RESEARCH 64 (16): 5882-5890 Zhang Z; Bast RC; Yu YH; Li JN; Sokoll LJ; et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer | 92 | 92 |
| 4 | 1 | 37 | 4 2005 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 192 (3): 710-718 Weiner CP; Lee KY; Buhimschi CS; Christner R; Buhimschi IA Proteomic biomarkers that predict the clinical success of rescue cerclage | 0 | 4 |
| 5 | 1 | 58 | 5 2005 AMERICAN JOURNAL OF PHARMACOGENOMICS 5 (3): 141-148 Tchabo NE; Liel MS; Kohn EC Applying proteomics in clinical trials - Assessing the potential and practical limitations in ovarian cancer | 0 | 0 |
| 6 | 1 | 22 | 6 2005 ANALYTICAL AND BIOANALYTICAL CHEMISTRY 381 (1): 24-27 Flad T; Tolson J Mass spectrometry meets medical sciences: making headway in molecular disease diagnostics | 0 | 0 |
| 7 | 1 | 26 | 7 2005 BIOINFORMATICS 21 (21): 4039-4045 Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SAL; Saha D; et al. Analysis of mass spectral serum profiles for biomarker selection | 0 | 0 |
| 8 | 1 | 30 | 8 2005 BIOLOGICAL & PHARMACEUTICAL BULLETIN 28 (6): 1031-1037 Kiga C; Nakagawa T; Koizumi K; Sakurai H; Shibagaki Y; et al. Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform | 0 | 0 |
| 9 | 2 | 40 | 9 2005 BIOMETALS 18 (6): 603-613 Zhai RH; Su SH; Lu X; Liao RQ; Ge XM; et al. Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers | 0 | 0 |
| 10 | 1 | 37 | 10 2005 BMC CANCER 5: Art. No. 133 Gericke B; Raila J; Sehouli J; Haebel S; Konsgen D; et al. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 11 | 1 | 65 | 11 2005 BULLETIN DU CANCER 92 (9): 763-768 Solassol J; Marin P; Maudelonde T; Mange A Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers | 0 | 0 |
| 12 | 1 | 78 | 12 2005 BULLETIN DU CANCER 92 (10): 874-884 Eisinger F Breast cancer screening for women with a strong familial risk | 0 | 0 |
| 13 | 1 | 103 | 13 2005 CANCER INVESTIGATION 23 (5): 465-478 Roboz J Mass spectrometry in diagnostic oncoproteomics | 0 | 0 |
| 14 | 1 | 1 | 14 2005 CANCER RESEARCH 65 (3): 1114-1114 Zhang Z; Chan DW Transthyretin, a biomarker for nutritional status and ovarian cancer - In response | 0 | 0 |
| 15 | 4 | 39 | 15 2005 CANCER RESEARCH 65 (22): 10613-10622 Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; et al. Possible detection of pancreatic cancer by plasma protein profiling | 0 | 0 |
| 16 | 2 | 85 | 16 2005 CLINICA CHIMICA ACTA 357 (2): 123-139 Righetti PG; Castagna A; Antonucci F; Piubelli C; Cecconi D; et al. Proteome analysis in the clinical chemistry laboratory: Myth or reality? | 0 | 1 |
| 17 | 1 | 29 | 17 2005 CLINICA CHIMICA ACTA 357 (2): 151-158 Colantonio DA; Chan DW The clinical application of proteomics | 2 | 2 |
| 18 | 1 | 6 | 18 2005 CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 33 (4): 339-340 Good WV; Gendron RL Retinopathy of prematurity: gone today, here tomorrow? | 0 | 0 |
| 19 | 1 | 26 | 19 2005 CLINICAL CANCER RESEARCH 11 (3): 963-965 Diamandis EP; van der Merwe DE Plasma protein profiling by mass spectrometry for cancer diagnosis: Opportunities and limitations | 4 | 10 |
| 20 | 1 | 27 | 20 2005 CLINICAL CANCER RESEARCH 11 (22): 8042-8047 Hayashida Y; Honda K; Osaka Y; Hara T; Umaki T; et al. Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 21 | 1 | 22 | 21 2005 CLINICAL CANCER RESEARCH 11 (23): 8312-8320 Li JN; Zhao J; Yu XD; Lange J; Kuerer H; et al. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid | 0 | 0 |
| 22 | 1 | 29 | 22 2005 CLINICAL CHEMISTRY 51 (1): 1-2 Coombes KR Analysis of mass spectrometry profiles of the serum proteome | 0 | 5 |
| 23 | 5 | 17 | 23 2005 CLINICAL CHEMISTRY 51 (8): 1525-1528 Karsan A; Eigl BJ; Flibotte S; Gelmon K; Switzer P; et al. Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis | 1 | 5 |
| 24 | 1 | 8 | 24 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (2): 125-126 White CN; Zhang Z; Chan DW Quality control for SELDI analysis | 2 | 2 |
| 25 | 2 | 31 | 25 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (12): 1281-1290 Bons JAP; Wodzig WKWH; van Dieijen-Visser MP Protein profiling as a diagnostic tool in clinical chemistry: a review | 1 | 2 |
| 26 | 5 | 55 | 26 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (12): 1314-1320 Clarke CH; Buckley JA; Fung ET SELDI-TOF-MS proteomics of breast cancer | 0 | 1 |
| 27 | 1 | 70 | 27 2005 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 8 (8): 669-677 Baggerman G; Vierstraete E; De Loof A; Schoofs L Gel-based versus gel-free proteomics: A review | 0 | 0 |
| 28 | 1 | 78 | 28 2005 DRUG DISCOVERY TODAY 10 (14): 965-976 Manne U; Srivastava RG; Srivastava S Recent advances in biomakers for cancer diagnosis and treatment | 0 | 1 |
| 29 | 1 | 159 | 29 2005 ELECTROPHORESIS 26 (2): 297-319 Righetti PG; Castagna A; Antonioli P; Boschetti E Prefractionation techniques in proteome analysis: The mining tools of the third millennium | 1 | 12 |
| 30 | 3 | 44 | 30 2005 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 5 (5): 735-743 Draghici S; Chatterjee M; Tainsky MA Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 31 | 1 | 23 | 31 2005 EXPERT REVIEW OF PROTEOMICS 2 (1): 139-145 Chertov O; Simpson JT; Biragyn A; Conrads TP; Veenstra TD; et al. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery | 0 | 2 |
| 32 | 4 | 85 | 32 2005 EXPERT REVIEW OF PROTEOMICS 2 (3): 315-324 Nedelkov D Population proteomic: addressing protein diversity in humans | 0 | 0 |
| 33 | 1 | 116 | 33 2005 EXPERT REVIEW OF PROTEOMICS 2 (3): 393-406 Lathrop JT; Hayes TK; Carrick K; Hammond DJ Rarity gives a charm: evaluation of trace proteins in plasma and serum | 0 | 0 |
| 34 | 1 | 93 | 34 2005 FEBS JOURNAL 272 (1): 2-15 Celis JE; Moreira JMA; Gromova I; Cabezon T; Ralfkiaer U; et al. Towards discovery-driven translational research in breast cancer | 1 | 9 |
| 35 | 1 | 33 | 35 2005 INTERNATIONAL JOURNAL OF CANCER 115 (5): 783-789 Fung ET; Yip TT; Lomas L; Wang Z; Yip C; et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays | 5 | 7 |
| 36 | 1 | 30 | 36 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15: 266-273 Boyce EA; Kohn EC Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets | 0 | 1 |
| 37 | 1 | 50 | 37 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15: 274-281 Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; et al. New tumor markers: CA125 and beyond | 0 | 1 |
| 38 | 1 | 85 | 38 2005 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 15 (5): 679-691 Duffy MJ; Bonfrer JM; Kulpa J; Rustin GJS; Soletormos G; et al. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use | 0 | 0 |
| 39 | 1 | 51 | 39 2005 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 46 (3): 863-876 Grus FH; Podust VN; Bruns K; Lackner K; Fu SY; et al. SELDI-TOF-MS ProteinChip Array profiling of tears from patients with dry eye | 0 | 1 |
| 40 | 3 | 115 | 40 2005 JOURNAL OF CLINICAL ONCOLOGY 23 (20): 4524-4531 Goggins M Molecular markers of early pancreatic cancer | 0 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 41 | 1 | 46 | 41 2005 JOURNAL OF IMMUNOTHERAPY 28 (3): 183-192 Stroncek DF; Burns C; Martin BM; Rossi L; Marincola FM; et al. Advancing cancer biotherapy with proteomics | 0 | 0 |
| 42 | 1 | 89 | 42 2005 JOURNAL OF PROTEOME RESEARCH 4 (3): 972-981 Koomen JM; Li DH; Xiao LC; Liu TC; Coombes KR; et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery | 1 | 3 |
| 43 | 1 | 33 | 43 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1098-1103 Srivastava S; Srivastava RG Proteomics in the forefront of cancer biomarker discovery | 0 | 1 |
| 44 | 2 | 92 | 44 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1143-1154 Gillette MA; Mani DR; Carr SA Place of pattern in proteomic biomarker discovery | 1 | 1 |
| 45 | 1 | 25 | 45 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1672-1680 Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC Identification of protein fragments as pattern features in MALDI-MS analyses of serum | 0 | 0 |
| 46 | 1 | 39 | 46 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1742-1751 Yu KH; Rustgi AK; Blair IA Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry | 0 | 0 |
| 47 | 1 | 36 | 47 2005 JOURNAL OF PROTEOME RESEARCH 4 (5): 1799-1804 Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; et al. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach | 0 | 0 |
| 48 | 1 | 25 | 48 2005 JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 16 (8): 1221-1230 Hood BL; Lucas DA; Kim G; Chan KC; Blonder J; et al. Quantitative analysis of the low molecular weight serum proteome using O-18 stable isotope labeling in a lung tumor xenograft mouse model | 0 | 2 |
| 49 | 1 | 24 | 49 2005 JOURNAL OF THE NATIONAL CANCER INSTITUTE 97 (4): 310-314 Liotta LA; Lowenthal M; Mehta A; Conrads TP; Veenstra TD; et al. Importance of communication between producers and consumers of publicly available experimental data | 7 | 10 |
| 50 | 2 | 47 | 50 2005 JOURNAL OF THE NATIONAL CANCER INSTITUTE 97 (4): 315-319 Ransohoff DF Lessons from controversy: Ovarian cancer screening and serum proteomics | 4 | 23 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 51 | 1 | 18 | 51 2005 JOURNAL OF UROLOGY 174 (4): 1213-1217 Hara T; Honda K; Ono M; Naito K; Hirohashi S; et al. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry | 1 | 1 |
| 52 | 1 | 56 | 52 2005 M S-MEDECINE SCIENCES 21 (8-9): 722-728 Solassol J; Boulle N; Maudelonde T; Mange A Clinical proteomics: towards early detection of cancers | 0 | 0 |
| 53 | 1 | 46 | 53 2005 MOLECULAR & CELLULAR PROTEOMICS 4 (4): 409-418 Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; et al. Biomarkers: Mining the biofluid proteome | 1 | 7 |
| 54 | 1 | 66 | 54 2005 MOLECULAR AND CELLULAR ENDOCRINOLOGY 230 (1-2): 95-106 Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ Proteomic patterns: their potential for disease diagnosis | 5 | 9 |
| 55 | 1 | 34 | 55 2005 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 592 (1-2): 147-154 Hayes RB; Sigurdson A; Moore L; Peters U; Huang WY; et al. Methods for etiologic and early marker investigations in the PLCO trial | 0 | 1 |
| 56 | 1 | 34 | 56 2005 NATURE BIOTECHNOLOGY 23 (3): 291-292 Coombes KR; Morris JRS; Hu JH; Edmonson SR; Baggerly KA Serum proteomics profiling - a young technology begins to mature | 5 | 10 |
| 57 | 3 | 51 | 57 2005 PHARMACOGENOMICS 6 (6): 647-653 Simpkins F; Czechowicz JA; Liotta L; Kohn EC SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics | 0 | 1 |
| 58 | 1 | 29 | 58 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (21): 7677-7682 Mor G; Visintin I; Lai Y; Zhao H; Schwartz P; et al. Serum protein markers for early detection of ovarian cancer | 3 | 6 |
| 59 | 1 | 18 | 59 2005 PROTEOMICS 5 (11): 2778-2788 Carlson SM; Najmi A; Whitin JC; Cohen HJ Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra | 0 | 0 |
| 60 | 2 | 182 | 60 2005 PROTEOMICS 5 (12): 3019-3034 Thadikkaran L; Siegenthaler MA; Crettaz D; Queloz PA; Schneider P; et al. Recent advances in blood-related proteomics | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 61 | 1 | 17 | 61 2005 PROTEOMICS 5 (13): 3343-3352 Misek DE; Kuick R; Wang H; Galchev V; Deng B; et al. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system | 0 | 1 |
| 62 | 1 | 30 | 62 2005 PROTEOMICS 5 (17): 4589-4596 Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; et al. Characterization of serum biomarkers for detection of early stage ovarian cancer | 0 | 0 |
| 63 | 1 | 31 | 63 2005 PROTEOMICS 5 (18): 4994-5001 Sun W; Li FX; Wu SZ; Wang XR; Zheng DX; et al. Human urine proteome analysis by three separation approaches | 0 | 2 |
| 64 | 1 | 38 | 64 2005 RAPID COMMUNICATIONS IN MASS SPECTROMETRY 19 (12): 1624-1636 Koomen JM; Zhao HT; Li DH; Nasser W; Hawke DH; et al. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting | 0 | 0 |
| 65 | 2 | 21 | 65 2005 REPRODUCTION 130 (6): 899-905 Katz-Jaffe MG; Linck DW; Schoolcraft WB; Gardner DK A proteomic analysis of mammalian preimplantation embryonic development | 0 | 0 |
| 66 | 1 | 68 | 66 2005 REVUE DE MEDECINE INTERNE 26 (6): 470-478 Goncalves A; Viens P; Sobol H; Maraninchi D; Bertucci F Molecular alterations in breast cancer: clinical implications and new analytical tools | 0 | 0 |
| 67 | 1 | 46 | 67 2005 THYROID 15 (6): 575-582 Diehl S; Umbricht CB; Dackiw APB; Zeiger MA Modern approaches to age-old questions about thyroid tumors | 0 | 0 |
| 68 | 1 | 25 | 68 2005 TRENDS IN PARASITOLOGY 21 (4): 154-157 Agranoff D; Stich A; Abel P; Krishna S Proteomic fingerprinting for the diagnosis of human African trypanosomiasis | 0 | 1 |
| 69 | 2 | 51 | 69 2006 BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY 20 (2): 321-338 Rosenthal A; Jacobs I Familial ovarian cancer screening | 0 | 0 |
| 70 | 1 | 25 | 70 2006 BRITISH JOURNAL OF CANCER 94 (2): 287-292 Ward DG; Cheng Y; N'Kontchou G; Thar TT; Barget N; et al. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 71 | 1 | 47 | 71 2006 CANCER RESEARCH 66 (3): 1376-1383 Moscova N; Marsh DJ; Baxter RC Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines | 0 | 0 |
| 72 | 1 | 31 | 72 2006 CANCER RESEARCH 66 (3): 1464-1472 Werbowetski-Ogilvie TE; Agar NYR; de Oliveira RMW; Faury D; Antel JP; et al. Isolation of a natural inhibitor of human malignant glial cell invasion: Inter alpha-trypsin inhibitor heavy chain 2 | 0 | 0 |
| 73 | 4 | 28 | 73 2006 CLINICA CHIMICA ACTA 366 (1-2): 249-256 Bons JAP; de Boer D; van Dieijen-Visser MP; Wodzig WKWH Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry | 0 | 0 |
| 74 | 3 | 46 | 74 2006 CLINICAL CANCER RESEARCH 12 (2): 323-327 Chambers AF; Vanderhyden BC Ovarian cancer biomarkers in urine | 0 | 0 |
| 75 | 2 | 48 | 75 2006 CLINICAL CANCER RESEARCH 12 (2): 432-441 Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; et al. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine | 1 | 1 |
| 76 | 3 | 6 | 76 2006 CLINICAL CHEMISTRY 52 (4): 772-772 Li JN; Zhang Z; Chan DW Validation of breast cancer biomarkers identified by mass spectrometry - Respond | 0 | 0 |
| 77 | 2 | 32 | 77 2006 CURRENT OPINION IN CHEMICAL BIOLOGY 10 (1): 50-55 Geho DH; Liotta LA; Petricoin EF; Zhao WD; Araujo RP The amplified peptidome: the new treasure chest of candidate biomarkers | 0 | 0 |
| 78 | 1 | 117 | 78 2006 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 6 (2): 179-191 Ginsburg GS; Haga SB Translating genomic biomarkers into clinically useful diagnostics | 0 | 0 |
| 79 | 2 | 20 | 79 2006 FERTILITY AND STERILITY 85 (1): 101-107 Katz-Jaffe MG; Gardner DK; Schoolcraft WB Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability | 0 | 0 |
| 80 | 1 | 17 | 80 2006 GYNECOLOGIC ONCOLOGY 100 (2): 247-253 Kong FB; White CN; Xiao XY; Feng YJ; Xu CJ; et al. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 81 | 1 | 21 | 81 2006 INTERNATIONAL JOURNAL OF CANCER 118 (2): 412-421 Lomnytska M; Dubrovska A; Hellman U; Volodko N; Souchelnytskyi S Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients | 0 | 0 |
| 82 | 1 | 43 | 82 2006 INTERNATIONAL JOURNAL OF CANCER 118 (7): 1750-1758 Le Page C; Ouellet W; Madore J; Hudson TJ; Tonin PN; et al. From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer | 0 | 0 |
| 83 | 2 | 36 | 83 2006 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 16: 139-146 Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; et al. Plasma proteomic pattern as biomarkers for ovarian cancer | 0 | 0 |
| 84 | 1 | 170 | 84 2006 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 16: 152-165 Crijns APG; Duiker EW; de Jong S; Willemse PHB; van der Zee AGJ; et al. Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy | 0 | 0 |
| 85 | 3 | 20 | 85 2006 JOURNAL OF CLINICAL INVESTIGATION 116 (1): 26-30 Liotta LA; Petricoin EF Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold | 0 | 0 |
| 86 | 4 | 79 | 86 2006 JOURNAL OF CLINICAL INVESTIGATION 116 (1): 271-284 Villanueva J; Shaffer DR; Philip J; Chaparro CA; Erdjument-Bromage H; et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns | 2 | 4 |
| 87 | 1 | 24 | 87 2006 JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 54 (1): 13-17 Ernst G; Melle C; Schimmel B; Bleul A; von Eggeling F Proteohistography - Direct analysis of tissue with high sensitivity and high spatial resolution using ProteinChip technology | 0 | 0 |
| 88 | 1 | 48 | 88 2006 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 147 (2): 83-90 Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; et al. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma | 0 | 0 |
| 89 | 1 | 34 | 89 2006 JOURNAL OF MOLECULAR DIAGNOSTICS 8 (1): 76-83 Steg A; Wang WQ; Blanquicett C; Grunda JM; Eltoum IA; et al. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array - Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma | 0 | 0 |
| 90 | 2 | 68 | 90 2006 JOURNAL OF PROTEOME RESEARCH 5 (1): 19-25 Ebert MPA; Korc M; Malfertheiner P; Rocken C Advances, challenges, and limitations in serum-proteome-based cancer diagnosis | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 91 | 2 | 37 | 91 2006 JOURNAL OF PROTEOME RESEARCH 5 (2): 254-261 Beyer S; Walter Y; Hellmann J; Kramer PJ; Kopp-Schneider A; et al. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra | 0 | 0 |
| 92 | 2 | 50 | 92 2006 ONCOGENE 25 (7): 981-989 Goncalves A; Esterni B; Bertucci F; Sauvan R; Chabannon C; et al. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy | 0 | 0 |
| 93 | 2 | 27 | 93 2006 PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 33 (1): 5-9 Li F; Fang Y; Xiao ZQ; Chen ZC Clinical proteomics: The application of proteomics in the research of clinical medicine | 0 | 0 |
Generated by HistCite 2006.02.28